• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由偶发分枝杆菌引起的肺部疾病的临床特征及治疗结果

Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera.

作者信息

Moon Seong Mi, Kim Su-Young, Jhun Byung Woo, Lee Hyun, Park Hye Yun, Jeon Kyeongman, Huh Hee Jae, Ki Chang-Seok, Lee Nam Yong, Shin Sung Jae, Koh Won-Jung

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Diagn Microbiol Infect Dis. 2016 Dec;86(4):382-384. doi: 10.1016/j.diagmicrobio.2016.09.016. Epub 2016 Sep 24.

DOI:10.1016/j.diagmicrobio.2016.09.016
PMID:27720208
Abstract

Mycobacterium chimaera is a recently described species distinct from M. intracellulare. M. chimaera is regarded as less virulent than M. intracellulare. Using multi-locus sequence-based identification, M. chimaera lung disease was diagnosed in 11 patients. Clinical characteristics and outcomes of M. chimaera lung disease were comparable to M. intracellulare lung disease.

摘要

嵌合体分枝杆菌是一种最近被描述的、与胞内分枝杆菌不同的菌种。嵌合体分枝杆菌被认为比胞内分枝杆菌的毒力更低。通过基于多位点序列的鉴定,在11名患者中诊断出嵌合体分枝杆菌肺病。嵌合体分枝杆菌肺病的临床特征和转归与胞内分枝杆菌肺病相当。

相似文献

1
Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera.由偶发分枝杆菌引起的肺部疾病的临床特征及治疗结果
Diagn Microbiol Infect Dis. 2016 Dec;86(4):382-384. doi: 10.1016/j.diagmicrobio.2016.09.016. Epub 2016 Sep 24.
2
Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.中国鸟分枝杆菌和胞内分枝杆菌肺病的危险因素和药物敏感性差异。
Int J Antimicrob Agents. 2015 May;45(5):491-5. doi: 10.1016/j.ijantimicag.2015.01.012. Epub 2015 Mar 1.
3
Comparison of methods available for identification of Mycobacterium chimaera.比较可用于鉴定耻垢分枝杆菌的方法。
Clin Microbiol Infect. 2018 Apr;24(4):409-413. doi: 10.1016/j.cmi.2017.07.031. Epub 2017 Aug 4.
4
Mycobacterium paraffinicum causing symptomatic pulmonary infection.引起症状性肺部感染的石蜡分枝杆菌。
J Clin Microbiol. 2014 Apr;52(4):1281-3. doi: 10.1128/JCM.03107-13. Epub 2014 Jan 22.
5
Mycobacterium riyadhense as the opportunistic infection that lead to HIV diagnosis: A report of 2 cases and literature review.里阿德分枝杆菌作为导致 HIV 诊断的机会性感染:2 例报告及文献复习。
J Infect Public Health. 2019 Mar-Apr;12(2):285-288. doi: 10.1016/j.jiph.2018.05.006. Epub 2018 Jun 6.
6
First case of nontuberculous mycobacterial lung disease caused by Mycobacterium marseillense in a patient with systemic lupus erythematosus.首例由马赛分枝杆菌引起的系统性红斑狼疮患者非结核分枝杆菌肺病。
Diagn Microbiol Infect Dis. 2014 Jul;79(3):355-7. doi: 10.1016/j.diagmicrobio.2014.03.019. Epub 2014 Mar 29.
7
Pulmonary disease in immunocompetent host: Treatment outcomes with short-course chemotherapy.免疫功能正常宿主的肺部疾病:短程化疗的治疗结果
Indian J Med Microbiol. 2016 Oct-Dec;34(4):516-519. doi: 10.4103/0255-0857.195370.
8
Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view.非结核分枝杆菌所致肺部疾病:一位流行病学家的观点。
Future Microbiol. 2010 Mar;5(3):343-5. doi: 10.2217/fmb.10.13.
9
as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.作为住院于肺病病房的 NTM 肺病患者的被低估病因。
Pol J Microbiol. 2021 Sep;70(3):315-320. doi: 10.33073/pjm-2021-028. Epub 2021 Sep 17.
10
Bacteriological and virulence study of a Mycobacterium chimaera isolate from a patient in China.来自中国一名患者的偶发分枝杆菌分离株的细菌学和毒力研究。
Antonie Van Leeuwenhoek. 2015 Apr;107(4):901-9. doi: 10.1007/s10482-015-0382-x. Epub 2015 Mar 13.

引用本文的文献

1
The State-of-the-Art of Infections and the Causal Link with Health Settings: A Systematic Review.感染的最新情况及其与健康环境的因果关系:一项系统综述。
Healthcare (Basel). 2024 Sep 6;12(17):1788. doi: 10.3390/healthcare12171788.
2
Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with complex-lung disease: A pilot study.通过下一代测序检测复杂肺部疾病患者循环中的微生物游离DNA:一项初步研究。
Tzu Chi Med J. 2023 Nov 7;36(1):67-75. doi: 10.4103/tcmj.tcmj_191_23. eCollection 2024 Jan-Mar.
3
Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report.
成人获得性免疫缺陷综合征患者播散性奇美拉分枝杆菌感染:病例报告。
BMC Infect Dis. 2022 Aug 1;22(1):665. doi: 10.1186/s12879-022-07656-0.
4
as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.作为住院于肺病病房的 NTM 肺病患者的被低估病因。
Pol J Microbiol. 2021 Sep;70(3):315-320. doi: 10.33073/pjm-2021-028. Epub 2021 Sep 17.
5
Mycobacterium chimaera infection masquerading as a lung mass in a healthcare worker.一名医护人员身上出现伪装成肺部肿块的分枝杆菌感染。
IDCases. 2019 Mar 26;15:e00526. doi: 10.1016/j.idcr.2019.e00526. eCollection 2019.
6
Mycobacterium chimaera Pulmonary Disease in Cystic Fibrosis Patients, France, 2010-2017.法国 2010-2017 年囊性纤维化患者中的奇美拉分枝杆菌肺病。
Emerg Infect Dis. 2019 Mar;25(3):611-613. doi: 10.3201/eid2503.181590.
7
Treatment of Complex Pulmonary Disease.复杂肺部疾病的治疗
Tuberc Respir Dis (Seoul). 2019 Jan;82(1):15-26. doi: 10.4046/trd.2018.0060.
8
Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.反复分枝杆菌肺病的结节性支气管扩张症间断抗生素治疗。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01812-17. Print 2018 Feb.
9
Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.33 株慢生长分枝杆菌参考菌株对 19 种抗菌药物的药敏性。
Biomed Res Int. 2017;2017:1584658. doi: 10.1155/2017/1584658. Epub 2017 Apr 20.
10
Target-Specific Assay for Rapid and Quantitative Detection of Mycobacterium chimaera DNA.用于快速定量检测嵌合体分枝杆菌DNA的靶向检测法
J Clin Microbiol. 2017 Jun;55(6):1847-1856. doi: 10.1128/JCM.00197-17. Epub 2017 Apr 5.